Chinese traditional medicine limit prescription Medicine province policy relaxed!

Medical Network September 16th, September 14th, Jiangsu Provincial Health and Health Commission issued "on the further clear non-Chinese medicine category of physicians to issue chinese medicine prescription management requirements notice", compared with the national level policy, Jiangsu relaxed the non-Chinese medicine category of doctors to issue Chinese medicine requirements, intended to promote the rapid development of Chinese medicine, play the important role of Chinese medicine in the treatment of diseases, disease treatment and rehabilitation.
Local policies relaxed According to the latest regulations in Jiangsu, non-Chinese medicine category physicians who want to prescribe Chinese medicine must meet the following conditions: First, non-Chinese medicine category physicians, obtain the qualifications of Chinese medicine category practicing assistant physicians, or obtain the education department recognized secondary specialty and above Chinese medicine, Chinese and Western medicine combination, ethnic medicine professional degree or degree , or to obtain the "Traditional Medicine Master Certificate" issued by the Provincial Administration of Traditional Chinese Medicine, or to participate in the provincial Chinese medicine authorities recognized more than 2 years of Western medicine training and obtain the corresponding certificate, can be issued traditional Chinese medicine, medical institutions, Chinese medicine preparations, Chinese medicine tablets prescriptions (including long-term prescriptions), and can carry out appropriate Chinese medicine technology.
, non-Chinese medicine category physicians after not less than 1 year of systematic study of Chinese medicine expertise and assessment of qualified, can be issued chinese medicine, medical institutions, Chinese medicine preparation prescriptions (including long-term prescriptions).
3. Non-Chinese medicine practitioners or rural doctors practising in primary health care institutions may prescribe commonly used traditional Chinese medicines (including long-term prescriptions) for common diseases and frequent illnesses, or they may continue to use long-term prescriptions for traditional Chinese medicines prescribed by Chinese medicine practitioners.
4. Before the issuance of the first batch of notice on the issuance of the national key monitoring and rational drug use drug catalogue (chemicals and biological products), a non-Chinese medicine class physician has been qualified and registered to practise, and who has received chinese medicine courses in college education and post-graduation education and has passed the results, may be prescribed traditional Chinese medicine, or may be prescribed a long-term prescription for chinese medicine commonly used in chronic diseases.
From the above conditions, the primary medical institutions of Western medicine will not be affected by the "limits", and the first batch of key monitoring of reasonable drug catalog before the release of Western medicine, as long as the Chinese medicine courses have been accepted and qualified results can be "open."
the requirements of the National Health and Health Commission, non-Chinese medicine doctors, without Chinese medicine-related education, Chinese medicine training experience, can not be prescribed traditional Chinese medicine.
after not less than 1 year of systematic study of Chinese medicine expertise and assessment of qualified, in accordance with the basic principles of dialectical treatment of Chinese medicine, can be issued prescriptions for traditional Chinese medicine.
However, the relevant person in charge of the National Health and Health Commission later explained that the purpose of the policy was to encourage Western medicine to study the theory of Traditional Chinese medicine and to use traditional Chinese medicine rationally, rather than to prohibit and restrict the prescription of traditional Chinese medicine by Western medicine.
scope of implementation is mainly used for the performance appraisal of three-level public hospitals, for county-level (second-level) hospitals do not make hard requirements.
to this, many provinces issued a statement that non-Chinese medicine practitioners practicing in level three hospitals should strictly implement the relevant provisions on the administration of prescriptions for traditional Chinese medicine, county-level (second-level) hospitals temporarily do not make rigid provisions.
Market pressure is observed that since the release of the policy, some areas of the hospital, especially the large triple-A hospital said that only Chinese medicine, Chinese and Western medicine combined categories of physicians can issue Chinese medicine tablets and traditional Chinese medicine, non-Chinese medicine category doctors can not issue Chinese medicine tablets and traditional Chinese medicine.
, since this year, all over the landing of the policy at the same time have shown an attitude to encourage the development of Chinese medicine.
On August 25, Guangxi Health and Wellness Commission issued the "Guangxi Zhuang Autonomous Region non-Chinese medicine category physicians and other personnel of Chinese medicine professional knowledge system learning and training assessment program (trial)" clearly: before June 13, 2019, has obtained a non-Chinese medicine category of physicians practice certificate, can continue to issue prescriptions for traditional Chinese medicine;
such personnel are not required to participate in the training assessment of this program.
And after June 13, 2019, non-Chinese medicine practitioners who have obtained a certificate of practice, doctors who need to prescribe traditional Chinese medicine, and non-Chinese medicine personnel who have entered the standardized training stage for residents will be trained in online learning and online assessment for one year.
can be issued after passing the assessment of Chinese medicine.
In recent years, the development of Chinese medicine has been under greater pressure, in some of the chinese medicine was cleared out of the medical insurance catalog, the exclusive variety of price reduction, Chinese medicine is likely to carry out volume procurement and many other policies under the influence of overlay, the market situation of Chinese medicine is not optimistic.
according to Milnet data, sales of Chinese medicines in urban public hospitals, county-level public hospitals, urban community centers and township hospital terminals in China in 2019 amounted to 283.018 billion yuan, down 1.7% YoY.
, the growth rate of the oral Chinese medicine market continued to slow down, the market for Chinese medicine injections declined significantly, and the overall Chinese medicine market experienced negative growth for the first time in 2019.
the first half of this year, the pharmaceutical industry released performance data show that traditional Chinese medicine showed negative growth, Chinese medicine tablets negative growth situation is more severe.
Some people in the industry believe that even if there is no outbreak of new crown pneumonia, in the consumption decline, domestic Chinese herbal medicine, drinking tablets quality is questioned in the environment, the Chinese medicine industry will still have negative growth, industry reshuffle accelerated.
industry has admitted that because the hospital has a lot of drug varieties, now many triple-A hospitals are kicking varieties out of hospital, Chinese medicine is the first to take the brunt.
same time, the Chinese medicine market is sinking, in clinics, private hospitals are doing well.
the industry, the impact of this policy may be mitigated by the relaxation of the conditions for Western medicine to prescribe Chinese medicine.
is also worth noting that during the outbreak of new crown pneumonia, Chinese medicine played an important role, the Chinese medicine industry or ushered in a new round of growth.
.